The Swiss pharmaceutical group said it will be completed in the second half of next year.
Arnd Wiegmann | Reuters
Novartis said on Thursday that it would spin off Sandoz and list it on the Swiss stock exchange to create Europe’s No.
“For both innovative pharmaceuticals and Sandoz businesses, this partnership will enable increased focus and ability to pursue independent growth strategies,” the Swiss pharmaceutical group said in a statement. create”.
It added that it is expected to be completed in the second half of next year.
